Rankings
▼
Calendar
BDSX Q3 2023 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$151M
Q3 2023 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$13M
+21.5% YoY
Gross Profit
$10M
76.1% margin
Operating Income
-$7M
-53.2% margin
Net Income
-$11M
-81.2% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+13.6%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$10M
Stock-Based Comp.
$954,000
Balance Sheet
Total Assets
$87M
Total Liabilities
$88M
Stockholders' Equity
-$1M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$13M
$11M
+21.5%
Gross Profit
$10M
$7M
+37.3%
Operating Income
-$7M
-$11M
+32.4%
Net Income
-$11M
-$14M
+20.1%
Revenue Segments
Diagnostic Tests
$12M
91%
Service
$1M
9%
← FY 2023
All Quarters
Q4 2023 →